Neomorph is a biotech company targeting protein degradation to eliminate disease-linked and previously labeled 'undruggable' proteins. The team's expertise in protein degradation and molecular glues allows them to develop heterobifunctional molecules that can degrade proteins using a molecular glue mechanism. Neomorph is collaborating with the Center for Protein Degradation at the Dana Farber Cancer Institute, as well as Novo Nordisk to discover and develop drugs for cardiometabolic and rare diseases. They were founded in 2020 with headquarters located in San Diego, CA.

Neomorph

Part-Time Compound Management Specialist (Temporary - 6 months)

Scientist I / II, Cell & Molecular Biology

Associate Principal Scientist, Computational Chemistry

Director, Virology

Carlos Huante Shares Neomorph Concept Art & Storyboards - Alien vs. Predator Galaxy

Alien: Covenant Photos Reveal Baby Neomorph, Ancient Temple & More - MovieWeb

Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs - Business Wire

AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology - PR Newswire

Sticky, sticky, sticky: Neomorph tacks on another Big Pharma glue degrader deal with $1.6B AbbVie pact - Fierce Biotech

Click here

 Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer 

New ‘Alien: Covenant’ Photos Reveal the Neomorph in All Its Gruesome Glory - ScreenCrush

Life-Sized ALIEN: COVENANT Neomorph Head Statue Is Mortifying - Nerdist

 Neomorph’s $1.6 Billion Collaboration with AbbVie 

Biogen and Neomorph enter molecular glue degrader deal - Pharmaceutical Technology

 Biogen, Neomorph announces multi-target research collaboration 

There Was Going to Be a Xenomorph vs Neomorph Fight in ‘Alien: Covenant’ - Bloody Disgusting

UBE2G1 governs the destruction of cereblon neomorphic substrates. Lu G, Weng S, Matyskiela M, Zheng X, Fang W, Wood S, Surka C, Mizukoshi R, Lu CC, Mendy D, Jang IS, Wang K, Marella M, Couto S, Cathers B, Carmichael J, Chamberlain P, Rolfe M. Elife. 2018 Sep 20;7:e40958. doi: 10.7554/eLife.40958. PMID: 30234487; PMCID: PMC6185104.
                    

Neomorph Announces Appointment of Dr. Klaus Wagner, M.D., Ph.D. as Chief Medical Officer - PR Newswire

Biogen, Neomorph pact worth $1.45B for molecular glue degraders - BioWorld Online

We're #hiring a new Scientist II, Biomolecular Simulations - Comp Chemistry in San Diego Metropolitan Area. Apply today or share this post with your network.


              Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases
            

Alien: Covenant Concept Art Reveals Early Neomorph Design - Screen Rant

Click here for Webcast

What is 'The Offspring' creature in the 'Alien: Romulus' finale? - Space

We're #hiring a new Senior / Executive Director, CMC in San Diego Metropolitan Area. Apply today or share this post with your network.

Neomorph, Inc.

Mixed results for Keytruda; AbbVie to work with Neomorph - BioPharma Dive

Neomorph vs Xenomorph fight scene was cut from Alien: Covenant - JoBlo.com

AbbVie and Neomorph seal glue degrader deal - The Pharma Letter

Protein degradation firm Neomorph racks up third pharma partner in $1.6B+ deal with AbbVie - FirstWord Pharma

Novo Nordisk sticks down $1.46B in biobucks for molecular glues with California biotech - Fierce Biotech

Morphological evolution of the neomorph in Choristodera. Red branches... - ResearchGate

 Neomorph, Inc. Announces Appointment of Chief Financial Officer 

We're #hiring a new Director, Virology in San Diego Metropolitan Area. Apply today or share this post with your network.

www.neomorph.com


                    Neomorph, Inc. to Participate in Upcoming Guggenheim Healthcare Talks – Targeted Protein Degradation Day
                

AbbVie and Neomorph enter molecular glue degrader partnership worth $1.64bn - PMLiVE

Neomorph Announces Appointment of Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors - PR Newswire

Neomorph, Inc. Announces Appointment of Chief Financial Officer - Business Wire

Last week, a few of our incredible female scientists participated in Women Who Inspire 2025, an event that celebrates the achievements, leadership, and impact of women in STEM. It was an inspiring day of connection, empowerment, and thought-provoking discussions.
 
At Neomorph, we’re proud to support and uplift the voices of women driving scientific breakthroughs. Thank you to Biocom California for hosting such an empowering event!

#WomenWhoInspire2025 #WomenInSTEM #LifeSciences #NeomorphInc #Biotech #Leadership #Biocom

Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact - MM+M Online


                    Philip Chamberlain Named as Chief Executive Officer of Neomorph
                

 Appointments and advancements for Jan. 15, 2025 

Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases - PR Newswire

We're #hiring a new Scientist II, Biology in San Diego Metropolitan Area. Apply today or share this post with your network.

 AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology 

 AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B 

Celebrating Hidetomo I. for his dedication, passion, and outstanding contributions to our team!

We're #hiring a new Senior Scientist, Computational Chemistry in San Diego, California. Apply today or share this post with your network.

Celebrating Deanna Taylor! Her expertise and commitment are invaluable. 

We are lucky to have you, Deanna!

Highlighting Fan Zheng for their remarkable achievements and hard work. 

Thank you for your commitment.

Molecular Glue Degraders Get Stickier With AbbVie/Neomorph Deal - insights.citeline.com

Neomorph Vs. Xenomorph Fight Almost Happened in Alien: Covenant - MovieWeb

Neomorph Pulls $109 Million - San Diego Business Journal

 AbbVie and Neomorph seal glue degrader deal 

Novo Nordisk signs $1.46bn deal to develop molecular glue therapies - Pharmaceutical Technology

We're #hiring a new Executive / Senior Executive Administrative Assistant in San Diego Metropolitan Area. Apply today or share this post with your network.

Alien: Covenant Rumors Include Neomorph - Cosmic Book News

 Already struggling booze biz dealt a new challenge: Crain's Daily Gist podcast 

Creating the Creature Effects of Alien Covenant - AvP Galaxy

Alien: Covenant Images Feature Neomorphs & Prometheus Connection - Screen Rant

On a dealmaking spree, AbbVie makes cancer, immunology pact with Neomorph - Crain's Chicago Business

 AbbVie, Neomorph to develop molecular glue degraders 

 Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases 

https://neomorph.com/index.html#news

Alien: Covenant's Neomorph Gets a Funko Vinyl Figure - Screen Rant

Check out the Terrifying new Neomorph in Ridley Scott’s Alien: Covenant - Motion Picture Association

Alien: Covenant Photos Show Bloody Neomorph Carnage - MovieWeb

Biogen buys in to molecular glues with Neomorph deal worth up to $1.45B - Fierce Biotech

Neomorph to Leverage $109 Million Series A Funds Against Undruggable Targets - BioSpace


                    Neomorph, Inc. Announces $109 Million Series A Financing to Advance Proprietary Protein Degradation Platform and Programs
                

 Substituted 2-(2,6-dioxopiperidin-3-yl)-5-(1-piperidin-4-yl)isoindoline-1,3- … 

Neomorph Lands $1.45B Biogen Pact - San Diego Business Journal

 Novo Nordisk sticks down $1.46B in biobucks for molecular glues 

AbbVie and Neomorph to develop glue degraders - Pharmaceutical Technology

'Alien: Covenant In Utero' Lets You Experience a Neomorph Birth in VR - Live Science

Neomorph, AbbVie strike $1.64 billion deal - statnews.com

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases - Biogen | Investor Relations

‘Alien: Covenant’ VFX Team Hatches New Neomorph, Xenomorphs - Hollywood Reporter

Fox Continues To Explore VR’s Selling Power With “Alien: Covenant In Utero” - Fast Company

Client Neomorph Collaborates with AbbVie to Develop Novel Molecular Glue Degraders for Up to $1.6 Billion - Ropes & Gray LLP

Celebrating Lisa Strong's remarkable contributions to our team. Keep up the great work!

AbbVie Teams Up With Neomorph for Molecular Glue Collab Worth up to $1.64B - BioSpace

 Neomorph Inks $1.46B Deal with Novo Nordisk 

Alien: 5 Reasons Why Neomorphs Are Deadlier Than Xenomorphs (& 5 Why They're Not) - Screen Rant

We're #hiring a new Vice President, Pharmacology & DMPK in San Diego Metropolitan Area. Apply today or share this post with your network.

Biogen forges $1.4B+ deal with Neomorph around molecular glue degraders - FirstWord Pharma

‘Alien: Covenant’: How the VFX Team Engineered Those Terrifying Xenomorph and Neomorph Creatures - Yahoo Entertainment

AVERON notebook to discover actionable cancer vulnerabilities enabled by neomorph protein-protein interactions - ScienceDirect.com

 Neomorph Pulls $109 Million 

 Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for ... 

Protocol to discover actionable cancer vulnerabilities enabled by neomorph protein-protein interactions with the AVERON Notebook - ScienceDirect.com

Neomorph - Alien vs. Predator Galaxy

Biogen, Neomorph partner to advance molecular glue degraders for neurologic conditions - Healio

 Neomorph, Abbvie to develop molecular glue degraders in $1.64B deal 

 Neomorph Lands $1.45B Biogen Pact 

Novo Inks Potential $1.46B Deal to Tap Neomorph’s Molecular Glue Platform - BioSpace

Novo Nordisk joins molecular glue club with Neomorph deal - pharmaphorum

Ridley Scott: Inspiration for Alien: Covenant's Neomorph - IGN

Biogen signs molecular glue deal, raises yearly projections - Endpoints News

AbbVie partners with Neomorph in latest molecular glue deal - Endpoints News

My Life as a Teenaged Neomorph: Experiencing ‘Alien Covenant: In Utero’ - The Knoxville Mercury

Neomorph

Business:

About: